U.S. markets closed
  • S&P Futures

    3,364.75
    -18.25 (-0.54%)
     
  • Dow Futures

    27,214.00
    -151.00 (-0.55%)
     
  • Nasdaq Futures

    11,537.75
    -50.25 (-0.43%)
     
  • Russell 2000 Futures

    1,574.40
    -14.60 (-0.92%)
     
  • Crude Oil

    38.65
    -0.92 (-2.32%)
     
  • Gold

    1,906.90
    -5.00 (-0.26%)
     
  • Silver

    24.40
    -0.17 (-0.69%)
     
  • EUR/USD

    1.1783
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    0.7780
    -0.0230 (-2.87%)
     
  • Vix

    33.35
    +0.89 (+2.74%)
     
  • GBP/USD

    1.3037
    -0.0004 (-0.03%)
     
  • USD/JPY

    104.3000
    -0.1940 (-0.19%)
     
  • BTC-USD

    13,796.87
    +42.11 (+0.31%)
     
  • CMC Crypto 200

    272.68
    +11.39 (+4.36%)
     
  • FTSE 100

    5,728.99
    -63.02 (-1.09%)
     
  • Nikkei 225

    23,410.76
    -75.04 (-0.32%)
     

Did You Participate In Any Of Varian Medical Systems' (NYSE:VAR) Fantastic 158% Return ?

Simply Wall St
·3 mins read

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of Varian Medical Systems, Inc. (NYSE:VAR) stock is up an impressive 129% over the last five years. It's also good to see the share price up 45% over the last quarter.

See our latest analysis for Varian Medical Systems

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Varian Medical Systems' earnings per share are down 7.0% per year, despite strong share price performance over five years.

Essentially, it doesn't seem likely that investors are focused on EPS. Because earnings per share don't seem to match up with the share price, we'll take a look at other metrics instead.

In contrast revenue growth of 3.9% per year is probably viewed as evidence that Varian Medical Systems is growing, a real positive. It's quite possible that management are prioritizing revenue growth over EPS growth at the moment.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

What about the Total Shareholder Return (TSR)?

Investors should note that there's a difference between Varian Medical Systems' total shareholder return (TSR) and its share price change, which we've covered above. Arguably the TSR is a more complete return calculation because it accounts for the value of dividends (as if they were reinvested), along with the hypothetical value of any discounted capital that have been offered to shareholders. We note that Varian Medical Systems' TSR, at 158% is higher than its share price return of 129%. When you consider it hasn't been paying a dividend, this data suggests shareholders have benefitted from a spin-off, or had the opportunity to acquire attractively priced shares in a discounted capital raising.

A Different Perspective

It's good to see that Varian Medical Systems has rewarded shareholders with a total shareholder return of 49% in the last twelve months. Since the one-year TSR is better than the five-year TSR (the latter coming in at 21% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 1 warning sign we've spotted with Varian Medical Systems .

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.